Terms: = Leukemia AND CALCB, Calcitonin AND Treatment
33 results:
1. CALCRL knockdown suppresses cancer stemness and chemoresistance in acute myeloid leukemia with FLT3-ITD and DNM3TA-R882 double mutations.
Tang S; Zhu H; Sheng L; Mu Q; Wang Y; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Drug Dev Res; 2024 Feb; 85(1):e22137. PubMed ID: 38349260
[TBL] [Abstract] [Full Text] [Related]
2. CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.
Tang S; Li S; Shi X; Sheng L; Mu Q; Wang Y; Zhu H; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Anticancer Drugs; 2024 Feb; 35(2):163-176. PubMed ID: 37948318
[TBL] [Abstract] [Full Text] [Related]
3. The CGRP Receptor Antagonist MK0974 Induces EVI1
Suekane A; Ichikawa T; Saito Y; Nakahata S; Morishita K
Anticancer Res; 2022 Oct; 42(10):4743-4752. PubMed ID: 36191988
[TBL] [Abstract] [Full Text] [Related]
4. Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
Shacham EC; Marshak DC; Brikman S; Dori G; Ishay A
Medicine (Baltimore); 2021 Apr; 100(14):e24982. PubMed ID: 33832072
[TBL] [Abstract] [Full Text] [Related]
5. The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.
Angenendt L; Bormann E; Pabst C; Alla V; Görlich D; Braun L; Dohlich K; Schwöppe C; Bohlander SK; Arteaga MF; Wethmar K; Hartmann W; Angenendt A; Kessler T; Mesters RM; Stelljes M; Rothenberg-Thurley M; Spiekermann K; Hébert J; Sauvageau G; Valk PJM; Löwenberg B; Serve H; Müller-Tidow C; Lenz G; Wörmann BJ; Sauerland MC; Hiddemann W; Berdel WE; Krug U; Metzeler KH; Mikesch JH; Herold T; Schliemann C
Leukemia; 2019 Dec; 33(12):2830-2841. PubMed ID: 31182782
[TBL] [Abstract] [Full Text] [Related]
6. Severe hypercalcemia: A rare and unusual presentation of acute lymphoblastic leukemia.
Dhivyasree S; Dhivyalakshmi J; Sankaranarayanan S; Scott JX
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1244-S1246. PubMed ID: 30539882
[TBL] [Abstract] [Full Text] [Related]
7. Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.
Rujirachun P; Junyavoraluk A; Owattanapanich W; Suvannarerg V; Sirinvaravong S
J Med Case Rep; 2018 Sep; 12(1):257. PubMed ID: 30196795
[TBL] [Abstract] [Full Text] [Related]
8. [Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
Gao HH; Yao ZL; Li Y; Huang S; Liu J; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):684-690. PubMed ID: 29950204
[TBL] [Abstract] [Full Text] [Related]
9. Chronic Myeloid leukemia Associated Hypercalcemia: A Case Report and Literature Review.
Toro-Tobón D; Agosto S; Ahmadi S; Koops M; Bruder JM
Am J Case Rep; 2017 Feb; 18():203-207. PubMed ID: 28239141
[TBL] [Abstract] [Full Text] [Related]
10. Severe Hypercalcemia in a Child With Acute Lymphoblastic leukemia Relapse: Successful Management With Combination of calcitonin and Bisphosphonate.
Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
[TBL] [Abstract] [Full Text] [Related]
11. Administration of calcitonin promotes blastocyst implantation in mice by up-regulating integrin β3 expression in endometrial epithelial cells.
Xiong T; Zhao Y; Hu D; Meng J; Wang R; Yang X; Ai J; Qian K; Zhang H
Hum Reprod; 2012 Dec; 27(12):3540-51. PubMed ID: 23001774
[TBL] [Abstract] [Full Text] [Related]
12. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.
Khoury N; Chang J; Gru AA; Whyte MP
J Clin Endocrinol Metab; 2012 Sep; 97(9):3051-5. PubMed ID: 22730513
[TBL] [Abstract] [Full Text] [Related]
13. Severe osteoporosis and high level TSH in a child before the diagnosis of acute lymphoblastic leukemia.
Atas A; Cakmak A; Soran M; Soker M; Varma M
J Pediatr Hematol Oncol; 2009 Aug; 31(8):588-91. PubMed ID: 19636264
[TBL] [Abstract] [Full Text] [Related]
14. treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
Bryant ML; Worthington MA; Parsons K
Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
[TBL] [Abstract] [Full Text] [Related]
15. The rapid correction of hypercalcemia at presentation of acute lymphoblastic leukemia using high-dose methylprednisolone.
Unal S; Durmaz E; Erkoçoğlu M; Bayrakçi B; Bircan O; Alikaşifoğlu A; Cetin M
Turk J Pediatr; 2008; 50(2):171-5. PubMed ID: 18664083
[TBL] [Abstract] [Full Text] [Related]
16. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Park JI; Strock CJ; Ball DW; Nelkin BD
Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
[TBL] [Abstract] [Full Text] [Related]
17. Hypermethylation of 5'-region of the human calcitonin gene in leukemias: structural features and diagnostic significance.
Marinitch DV; Vorobyev IA; Holmes JA; Zakharchenko NS; Dyachenko OV; Buryanov YI; Shevchuk TV
Biochemistry (Mosc); 2004 Mar; 69(3):340-9. PubMed ID: 15061703
[TBL] [Abstract] [Full Text] [Related]
18. [Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia].
Xie XH; Chen ZZ; Zhang XM; Huang MQ
Ai Zheng; 2003 Jun; 22(6):616-9. PubMed ID: 12948412
[TBL] [Abstract] [Full Text] [Related]
19. treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract] [Full Text] [Related]
20. [Life threatening hypercalcemia in a young man with ALL].
Schneider T; Seydlitz F; Zimmermann U; Sontag B; Boesken WH
Dtsch Med Wochenschr; 2001 Jan; 126(1-2):7-11. PubMed ID: 11200666
[TBL] [Abstract] [Full Text] [Related]
[Next]
